| 2002 |
ER71 is a constitutively nuclear protein whose intracellular localization depends on a portion of the ETS domain (amino acids 276-315). The N-terminus of ER71 negatively regulates DNA binding, while the C-terminus dramatically enhances DNA binding activity. ER71 possesses a potent N-terminal transactivation domain (amino acids 1-157) and directly activates the matrix metalloproteinase-1 promoter via an E74 site. |
Deletion mutagenesis, reporter assays, nuclear localization analysis |
Nucleic acids research |
Medium |
12087183
|
| 2006 |
TSGA/Jmjd1a interacts with ER71 both in vitro and in vivo; the N-terminus of TSGA and C-terminus of ER71 mediate complex formation. TSGA represses ER71-dependent transcriptional activation of the MMP-1 promoter. |
Co-immunoprecipitation, in vitro binding assay, reporter assay |
Journal of cellular biochemistry |
Medium |
16619273
|
| 2008 |
ER71 acts downstream of BMP, Notch, and Wnt signaling to regulate FLK1+ mesoderm specification. Inhibition of BMP, Notch, and Wnt signaling decreased FLK1+ mesoderm and ER71 expression; enforced ER71 expression rescued FLK1+ mesoderm generation blocked by these inhibitors. Er71-deficient mice lacked FLK1 expression and displayed severe blood and vessel defects reminiscent of Flk1 null mice. |
Embryonic stem cell differentiation, pathway inhibition, genetic knockout, gain-of-function rescue |
Cell stem cell |
High |
18462699
|
| 2008 |
Human ETV2/ER71 and mouse ER71 are functional orthologs of zebrafish Etsrp. Overexpression of mouse ER71 caused expansion of hemangioblast and vascular endothelial lineages in zebrafish. Etsrp functions cell-autonomously in inducing myeloid lineage, and the choice of endothelial versus myeloid fate depends on combinatorial effects of etsrp, scl, and alk8. |
Zebrafish overexpression, mosaic analysis, morpholino knockdown |
Blood |
High |
18270322
|
| 2011 |
Etv2 is dispensable for generating primitive Flk-1+/PDGFRα+ mesoderm but required for the progression of these cells into Flk-1+/PDGFRα- vascular/hematopoietic mesoderm. Key downstream targets include Scl, Fli1, and GATA2. Expression of Scl or Fli1 alone could restore HPCs/ECs in Etv2-null background. VEGF potently and rapidly induces Etv2 in Flk-1+ mesoderm. |
ESC differentiation, Etv2-null embryo analysis, re-expression rescue experiments, gene expression profiling |
Blood |
High |
21911838
|
| 2011 |
In the absence of ER71, cells that would normally become hematopoietic and endothelial lineages are redirected to cardiac lineages, including cardiomyocytes. ER71-expressing cells give rise to hematopoietic and endothelial lineages in wild-type, but contribute to cardiac lineage in Er71 mutants. ER71 overexpression repressed cardiogenesis. |
Er71-EYFP transgenic mouse, Er71-Cre genetic fate mapping, FACS, transcriptional profiling, inducible ES/EB system |
Development (Cambridge, England) |
High |
21989919
|
| 2011 |
Etsrp-expressing vascular endothelial/endocardial progenitors differentiate as cardiomyocytes in the absence of Etsrp function. Etsrp directly induces endocardial nfatc1 expression to regulate endocardial differentiation. Etsrp inhibits myocardial differentiation through a distinct mechanism from endocardial induction. Foxc1a interaction with Etsrp is required to initiate endocardial development but dispensable for inhibition of myocardial differentiation. |
Zebrafish morpholino knockdown, mutant analysis, lineage tracing |
Development (Cambridge, England) |
High |
21989916
|
| 2011 |
Foxc1a and Foxc1b directly regulate etsrp expression in angioblasts. ChIP showed Foxc1a/b binding to an enhancer 2.3 kb upstream of etsrp containing a consensus FOX binding site. Combined knockdown of foxc1a/b decreased etsrp expression at early developmental stages. |
EMSA, ChIP, morpholino knockdown, transgenic reporter analysis |
Circulation research |
High |
22135404
|
| 2012 |
ER71 specifies Flk-1+PDGFRα- hemangiogenic mesoderm by negatively regulating cardiac and Wnt signaling pathway genes. ER71 inhibits Wnt signaling through VE-cadherin-independent and VE-cadherin-dependent (VE-cadherin/β-catenin/Flk-1 complex formation) mechanisms. Enforced β-catenin rescued cardiogenic mesoderm in the context of ER71 overexpression. |
ESC differentiation, gain/loss-of-function, β-catenin rescue experiments, gene expression analysis |
Blood |
High |
22343916
|
| 2012 |
PKA/CREB signaling activates Etv2 transcription to trigger endothelial and hematopoietic cell differentiation. Two CRE sequences in the Etv2 promoter and 5'-UTR were identified; CREB directly binds these CRE sites. Dominant negative CREB completely inhibited PKA-elicited Etv2 expression and EC/HPC induction from ESCs. |
Promoter analysis, CREB binding confirmation, dominant-negative CREB, PKA inhibition, ex vivo embryo culture |
Stem cells (Dayton, Ohio) |
High |
22267325
|
| 2012 |
SRY binds to and activates the Er71 promoter. In turn, ER71 binds to the Sox9 promoter and activates Sox9 transcription; mutation of the ER71 binding site suppressed this activation. SOX9 also binds the Er71 promoter, and Sox9 downregulation reduced Er71 levels, forming a positive autoregulatory loop between ER71 and SOX9 in testis. |
Promoter binding assays, site-directed mutagenesis, dominant-negative ER71, ChIP, luciferase reporter assays |
The Journal of biological chemistry |
High |
22613723
|
| 2012 |
ETV2 is required for the formation of hemogenic endothelium; ETV2 deficiency results in a complete absence of hemogenic endothelium in differentiating ES cells and gastrulating embryos. |
ETV2::GFP transgenic mouse, ES cell differentiation, FACS sorting, in vivo embryo analysis |
Developmental dynamics |
High |
22733530
|
| 2012 |
ETV2 acts prior to or at the time of FLK1 expression in mesodermal precursors. ETV2 re-expression in Etv2-/- Flk1-negative precursors drives hematopoiesis specification and switches on SCL, GATA2, and FLI1 expression. SCL re-expression in Etv2-/- cells fully rescues hematopoiesis, while FLI1 or GATA2 re-expression provides only limited rescue. |
Cre-mediated ETV2 deletion, Flk1-Cre, ESC differentiation rescue experiments |
Stem cells (Dayton, Ohio) |
High |
22570122
|
| 2013 |
Etv2 expression alone is sufficient to transdifferentiate fast skeletal muscle cells into functional blood vessels in vivo. The canonical Wnt pathway is important for induction of transdifferentiation, while the VEGF pathway provides a maturation signal for endothelial fate. Mammalian myoblasts, but not other cell types examined, induced vascular gene expression upon Etv2 overexpression. |
Heat shock-inducible Etv2 zebrafish transgene, time-lapse imaging, lineage tracing, immunostaining, pharmacological/transgenic/morpholino approaches |
PLoS biology |
High |
23853546
|
| 2013 |
Forced expression of Etv2 rescued both hematopoietic and endothelial potential of differentiating Flk1-/- and Etv2-/- cells, whereas forced Flk1 expression rescued only Flk1-/- but not Etv2-/- cells. This demonstrates that Etv2 functions downstream of or parallel to Flk1 and that disruption of Etv2 expression is responsible for early phenotypes of Flk1 mutant embryos. |
Inducible viral rescue of knockout ESCs, EB differentiation |
Genesis |
Medium |
23606617
|
| 2013 |
Post-transcriptional repression by let-7 family microRNAs contributes to Etv2 downregulation during vascular development. The etv2 3'UTR contains binding sites for let-7 miRNAs; ectopic let-7a repressed the etv2 3'UTR and blocked endogenous Etv2 protein expression. Etv2 protein persisted in maternal-zygotic dicer1 mutant zebrafish embryos. |
Inducible Etv2 knockdown, 3'UTR reporter assays, miRNA overexpression, dicer1 mutant analysis |
Developmental biology |
Medium |
24036310
|
| 2014 |
Etv2 interacts with Gata2 in vitro and in vivo; the interaction is mediated by the Ets and Gata domains. Co-expression of Gata2 augments Etv2 activity in promoting endothelial and hematopoietic lineage differentiation. Etv2 and Gata2 both bind the Spi1 promoter in vitro and in vivo. |
Co-immunoprecipitation, GST pulldown, ChIP, embryoid body differentiation |
Developmental biology |
High |
24583263
|
| 2014 |
Etv2 binds to conserved Ets-binding sites in the Fli1 promoter and governs Fli1 expression. After Etv2 expression ceases at midgestation, Fli1 protein itself binds those same Ets-binding sites in a positive autoregulatory loop, maintaining Fli1 expression and selective Etv2-regulated endothelial genes. Fli1 also binds the Tie2 promoter/enhancer to control its expression beyond midgestation. |
ChIP, promoter binding assays, loss/gain-of-function, endothelial cell survival assays |
Circulation research |
High |
24727028
|
| 2014 |
OVOL2, a C2H2 zinc finger protein, directly interacts with ER71/ETV2 in the nucleus. OVOL2 enhances ER71-mediated activation of the Flk1 promoter. Co-expression of ER71 and OVOL2 augmented FLK1+, endothelial, and hematopoietic cell generation from differentiating ESCs. |
Co-immunoprecipitation, luciferase reporter assay, ESC differentiation, shRNA knockdown |
Blood |
Medium |
25267199
|
| 2014 |
ETV2 directly regulates Sox7 by binding ETV2 binding elements in the Sox7 upstream regulatory region and activating transcription. SOX7 overexpression mimics ETV2 in increasing endothelial progenitor cells, while Sox7 knockdown blocks ETV2-induced endothelial progenitor formation and angiogenic sprouting. |
ChIP, luciferase reporter assay, shRNA knockdown, embryoid body differentiation |
Stem cells and development |
Medium |
24762086
|
| 2014 |
FoxC2 and Etv2 cooperatively activate a FOX:ETS composite motif in the ECE1 arterial enhancer. Additionally, Sox17 binds a conserved SOX site in the same enhancer, and the ECE1 enhancer is cooperatively activated by combinatorial action of FoxC2, Etv2, and Sox17. |
Transgenic mouse reporter assay, EMSA, promoter mutagenesis |
Developmental biology |
Medium |
25179465
|
| 2015 |
ETV2 binds to enhancers that specify hematopoietic and endothelial cell lineages (global ChIP-seq). ETV2 activates other Ets genes (Fli1, Erg, etc.), establishing an ETS hierarchy, and the hematopoietic/endothelial program initiated by ETV2 is maintained by other ETS factors through an ETS switching mechanism. The hemangiogenic progenitor population (FLK1highPDGFRα-) is exclusively sensitive to ETV2-dependent FLK1 signaling. |
ChIP-seq, ESC differentiation, germ-line and conditional knockout mouse studies |
EMBO reports |
High |
25802403
|
| 2015 |
Etv2 and Fli1b share the same transcriptional targets and bind to the same ETS sites, as shown by RNA-Seq and ChIP. Etv2 and Fli1b function redundantly during late vasculogenesis and early embryonic angiogenesis, with two distinct phases: Etv2 alone required for early vasculogenesis, Etv2 and Fli1b redundant during late vasculogenesis/early angiogenesis. |
Zebrafish mutants, RNA-Seq, ChIP, photoactivatable morpholinos, overexpression |
Arteriosclerosis, thrombosis, and vascular biology |
High |
25722433
|
| 2015 |
Etv2 directly activates miR-130a. miR-130a promotes the endothelial program at the expense of cardiac program by directly suppressing Pdgfra expression and blocking Pdgfra signaling. CRISPR/Cas9 knockout of miR-130a reduced the endothelial program without affecting hematopoiesis. |
ChIP, CRISPR/Cas9 knockout, gain-of-function, Dicer ablation in Etv2-expressing cells, ESC/EB differentiation |
Cell reports |
High |
26565905
|
| 2015 |
Endothelial ETV2 is required for injury-induced vascular regeneration. Etv2 expression is reactivated in endothelial cells after injury (but not detectable at steady-state). ETV2 upregulates Flk1/VEGFR2 expression after injury; Flk1 expression rescued angiogenesis defects in endothelial Etv2 conditional knockout mice. Etv2+/-;Flk1+/- double heterozygous mice showed more severe ischemic injury response, establishing epistatic interaction between ETV2 and FLK1. |
Endothelial-specific conditional knockout, ischemia models, lentiviral rescue, double heterozygous epistasis |
Arteriosclerosis, thrombosis, and vascular biology |
High |
26586661
|
| 2015 |
LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2. Hematopoietic defects in lsd1 mutant zebrafish were rescued by knockdown of etv2, placing LSD1 upstream of Etv2 in hemangioblast fate commitment. |
Zebrafish mutant screen, morpholino knockdown rescue, genetic epistasis |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
26512114
|
| 2017 |
Vegf signaling promotes vascular endothelial differentiation by modulating Etv2 expression. Vegfr inhibition reduced etv2 expression; Vegfaa overexpression expanded etv2 expression. Vascular-specific overexpression of etv2 in Vegfr-inhibited embryos rescued defects in vascular endothelial differentiation, placing Etv2 downstream of Vegf signaling. |
Chemical Vegfr inhibition, genetic mutants, overexpression rescue, zebrafish embryos |
Developmental biology |
High |
28279709
|
| 2017 |
ETV2 directly binds promoter region of Rhoj, serving as upstream transcriptional regulator of cell migration. ETV2 overexpression enhanced cell migration in ESCs, embryoid bodies, and fibroblasts; Etv2 knockout led to migratory defects of angioblasts in developing embryos. shRNA knockdown of Rhoj caused migration defects partially rescued by ETV2 overexpression. |
ChIP-seq, ATAC-seq, RNAseq, migration assays, Etv2 knockout embryos, shRNA knockdown rescue |
Arteriosclerosis, thrombosis, and vascular biology |
High |
33115267
|
| 2017 |
IP3R-mediated Ca2+ signals govern hematopoietic versus cardiac fate of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway. Constitutively active NFATc3 rescued Etv2 expression in IP3R-knockout cells. NFATc3 directly targets Etv2 via an evolutionarily conserved cis-element. |
IP3R triple knockout ESCs, Ca2+ manipulation, calcineurin activation, NFATc3 constitutively active expression, ChIP |
Journal of molecular cell biology |
Medium |
28419336
|
| 2017 |
Foxh1, in part through Eomes, is critical for FLK1+ mesoderm formation. Hemangiogenic fate is specified through a threshold-dependent mechanism in which VEGF-FLK1 signaling plays an instructive role by promoting Etv2 threshold expression. |
Genome-wide CRISPR screen, Brachyury/Etv2/Scl reporter ESC lines, transcriptome analysis |
Nature communications |
High |
28912455
|
| 2018 |
ETV2 is sufficient and necessary for transdifferentiation of CD133+/Nestin+ GBM/neural stem cells to endothelial lineage. ChIP-Seq combined with gain-of-function RNA-Seq showed that ETV2 activates vascular genes and represses proneural genes to direct endo-transdifferentiation. This process is VEGF-A independent. |
ChIP-Seq, RNA-Seq, gain/loss-of-function experiments |
Signal transduction and targeted therapy |
Medium |
29527330
|
| 2018 |
ETV2 directly binds promoter/enhancer regions of Vegfr3/Flt4 and lymphatic marker Lyve1, promoting their expression. Etv2 inhibition at 1 dpf inhibited lymphangiogenesis while blood vessel development was unaffected, and lymphatic progenitors failed to respond to Vegfc signaling in Etv2-deficient embryos. |
Photoactivatable morpholinos, ChIP-seq, luciferase reporter assays, zebrafish embryos |
Developmental biology |
High |
29753018
|
| 2018 |
ETV2 directly interacts with TET1 and TET2 methylcytosine-converting enzymes. ETV2 binds ETS motifs in the Robo4 promoter and activates expression. ETV2-TET1/TET2 complexes demethylate the Robo4 promoter in non-endothelial cells, providing a mechanism for EC-specific gene expression via promoter demethylation. |
Co-immunoprecipitation, reporter assay, adenoviral expression, methylation analysis |
Scientific reports |
Medium |
29618782
|
| 2019 |
cAMP/EPAC/RAP1 signaling facilitates ETV2-mediated endothelial transdifferentiation. ChIP-seq showed majority of ETV2 targets in human fibroblasts are related to vasculature development and Rap1 signaling. Activation of cAMP/EPAC/RAP1 axis improved efficiency and quality of ETV2-induced endothelial cells. |
ChIP-seq, pharmacological pathway activation, in vivo and in vitro functional assays |
Molecular therapy |
Medium |
31864907
|
| 2019 |
ETV2 transcriptionally regulates Yes1 as a direct upstream regulator during embryogenesis. Doxycycline-mediated Etv2 induction increased Yes1 in a dose-dependent manner. Etv2 induction also caused ~2.5-fold increase in cellular proliferation, associated with upregulation of cell cycle genes E2f4 and Ccne1. |
ChIP-seq analysis, RNAseq, EdU-incorporation, doxycycline-inducible Etv2 ES/EB system, single-cell RNA-seq |
Scientific reports |
Medium |
31278282
|
| 2019 |
ETV2/ER71 directly induces miR-126, which positively regulates FLK1+ cell generation by activating the MAPK pathway through targeting SPRED1. JUN/FOS activate the FLK1 enhancer through AP1 binding sequences downstream of this miR-126-MAPK axis. |
miRNA sequencing, ChIP-PCR, signaling pathway analysis |
Stem cell research & therapy |
Medium |
31744543
|
| 2022 |
ETV2 functions as a pioneer factor that binds nucleosomal DNA and recruits BRG1. BRG1 recruitment remodels chromatin around endothelial genes and helps maintain an open configuration, resulting in increased H3K27ac deposition, thereby regulating endothelial development. |
Multi-omics (ATAC-seq, ChIP-seq), engineered ESC differentiation and reprogramming models, nucleosome binding assays |
Nature cell biology |
High |
35550615
|
| 2022 |
ETV2 functions as a pioneer transcription factor initiating Shh expression during limb development by changing chromatin status of the ZRS limb enhancer. ETV2 binds nucleosome-occupied ZRS, causes nucleosomal displacement at ETS binding site clusters, and is antagonized by ETV4/5 repressors. Known human polydactyl mutations introduce novel ETV2 binding sites in the ZRS. |
Etv2 conditional inactivation, Etv2 overexpression in limb buds, ATAC-seq, ChIP-seq, luciferase reporter assays |
Nature communications |
High |
35864091
|
| 2022 |
Etv2 dosage determines fate between hemogenic and aortic endothelium from a common hemogenic angioblast precursor. High Etv2 dosage specifies hemogenic endothelial cells while low Etv2 specifies conventional endothelium. |
Photoconvertible labeling, time-lapse imaging, single-cell RNA-sequencing, zebrafish |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
35333649
|
| 2022 |
Etv2 functions directly in a coherent feedforward transcriptional network for vascular endothelial development. Low-level Etv2 expression is sufficient to induce and sustain the endothelial GRN, whereas a significantly higher threshold of Etv2 is required to initiate and sustain erythropoietic development. Etv2 induces the erythropoietic GRN indirectly via activation of Tal1. |
Hypomorphic Etv2 mutant analysis, gene regulatory network analysis |
Cell reports |
Medium |
35649376
|
| 2022 |
Bmp signalling acts upstream of etv2 in regulating endocardial identity in zebrafish. Overactivation of Bmp signalling was unable to restore endocardial expression in etv2 mutants, but overexpression of etv2 rescued endocardial expression upon Bmp inhibition, establishing etv2 downstream of Bmp. |
Zebrafish etv2 and npas4l mutants, Bmp gain/loss of function, epistasis experiments |
Development (Cambridge, England) |
Medium |
35531980
|
| 2023 |
ETV2 directly interacts with VEZF1 (vascular endothelial zinc finger 1), as demonstrated by yeast two-hybrid, co-immunoprecipitation, and GST pulldown. VEZF1 co-activates ETV2-dependent Flt1 promoter activity. VEZF1 binds the Flt1 promoter in vitro and in vivo (EMSA and ChIP). |
Yeast two-hybrid, co-immunoprecipitation, GST pulldown, luciferase reporter, EMSA, ChIP, Vezf1 knockout ESCs |
Frontiers in cell and developmental biology |
High |
36923254
|
| 2023 |
ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment. ETV2 binding at hematoendothelial regulator genes precedes transcriptional activation; the shift from ETV2 binding to ETV2-bound enhancer activation drives hematoendothelial fate commitment. |
scRNA-seq, ATAC-seq, chromatin accessibility analysis of fate intermediates in mouse |
Cell reports |
Medium |
37330911
|
| 2024 |
ETV2 interacts with KDM4A, an H3K9 demethylase; Etv2-null ESCs exhibit enhanced H3K9me3 levels at hematopoietic and endothelial genes. ETV2-mediated transcriptional activation of hematopoietic and endothelial genes depends on KDM4A histone demethylase activity. Cdh5Cre:Kdm4a;Etv2 double conditional knockout mice show more severe vascular regeneration defects than single knockouts. |
Co-immunoprecipitation, H3K9me3 ChIP, conditional double knockout mice, vascular perfusion assays |
iScience |
High |
39811655
|
| 2024 |
BCL6B binds the promoter region of ETV2 and suppresses ETV2's transcriptional activity, thereby inhibiting endothelial cell differentiation from hiPSCs. ETV2 overexpression rescued the inhibitory effect of BCL6B overexpression on EC differentiation. |
Luciferase reporter assay, ChIP-PCR, doxycycline-inducible hiPSC systems, rescue experiments |
Stem cell research & therapy |
Medium |
39075623
|
| 2025 |
ETV2 pioneer activity both directs EC specification and suppresses alternative fate acquisition. ETV2 recruits the transcriptional repressor REST to repress non-EC lineage genes. GABPA is identified as a cofactor essential for efficient EC specification downstream of ETV2. |
CUT&RUN, scRNA-seq, scATAC-seq, functional screening, candidate validation |
Nature cardiovascular research |
High |
40495012
|
| 2017 |
Etv2 transcriptionally regulates miR-130a-Jarid2: Etv2-Cre Dicer ablation disrupts vascular patterning. miR-130a directly regulates Jarid2 expression by binding its 3'-UTR, promoting angiogenesis. Jarid2 overexpression leads to defective tube formation; miR-130a morpholino injection in zebrafish results in perturbed vascular patterning with increased Jarid2 levels. |
Etv2-Cre DicerL/L, miR-130a overexpression, Jarid2 3'UTR binding, zebrafish morpholinos, HUVEC tube formation |
PloS one |
Medium |
29232705
|
| 2024 |
PPARγ transcriptionally activates the ETV2 promoter. Endothelial PPARγ overexpression increases ETV2 expression and endothelial markers, while PPARγ knockout decreases ETV2 expression. Etv2 haploinsufficient mice spontaneously developed pulmonary hypertension and right ventricular hypertrophy with increased EndoMT markers. |
Promoter reporter assay, conditional knockout/overexpression mouse models, EndoMT model |
Pulmonary circulation |
Medium |
39391221
|